GenMont Biotech Incorporation (3164.TW)
TWD 18.3
(-1.88%)
TWD 18.3
(-1.88%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.38 TWD | -42.42% |
| 2022 | 0.66 TWD | -49.62% |
| 2021 | 1.31 TWD | 89.86% |
| 2020 | 0.69 TWD | 6.15% |
| 2019 | 0.65 TWD | -63.48% |
| 2018 | 1.78 TWD | 249.02% |
| 2017 | 0.51 TWD | 119.25% |
| 2016 | -2.65 TWD | -140.91% |
| 2015 | -1.10 TWD | 81.1% |
| 2014 | -5.82 TWD | -1241.18% |
| 2013 | 0.51 TWD | -1.92% |
| 2012 | 0.52 TWD | -27.78% |
| 2011 | 0.72 TWD | -74.1% |
| 2010 | 2.78 TWD | 71.6% |
| 2009 | 1.62 TWD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.40 TWD | 1816.74% |
| 2024 Q2 | 0.17 TWD | -57.5% |
| 2023 Q2 | 0.03 TWD | -49.93% |
| 2023 Q3 | 0.28 TWD | 738.32% |
| 2023 FY | - TWD | -42.42% |
| 2023 Q4 | -0.02 TWD | -108.32% |
| 2023 Q1 | 0.07 TWD | -58.31% |
| 2022 Q4 | 0.16 TWD | 163.16% |
| 2022 FY | - TWD | -49.62% |
| 2022 Q3 | 0.06 TWD | -56.57% |
| 2022 Q2 | 0.14 TWD | -48.15% |
| 2022 Q1 | 0.27 TWD | -44.9% |
| 2021 Q1 | 0.35 TWD | 302.3% |
| 2021 FY | - TWD | 89.86% |
| 2021 Q4 | 0.49 TWD | 81.48% |
| 2021 Q3 | 0.27 TWD | 58.82% |
| 2021 Q2 | 0.17 TWD | -51.43% |
| 2020 Q1 | 0.10 TWD | 330.95% |
| 2020 Q2 | 0.17 TWD | 70.0% |
| 2020 Q3 | 0.33 TWD | 94.12% |
| 2020 FY | - TWD | 6.15% |
| 2020 Q4 | 0.09 TWD | -73.64% |
| 2019 FY | - TWD | -63.48% |
| 2019 Q1 | 0.46 TWD | 64.29% |
| 2019 Q3 | 0.18 TWD | 260.0% |
| 2019 Q2 | 0.05 TWD | -89.13% |
| 2019 Q4 | -0.04 TWD | -124.06% |
| 2018 Q1 | 0.05 TWD | 127.78% |
| 2018 FY | - TWD | 249.02% |
| 2018 Q4 | 0.28 TWD | -31.71% |
| 2018 Q3 | 0.41 TWD | -60.95% |
| 2018 Q2 | 1.05 TWD | 2000.0% |
| 2017 Q2 | 0.46 TWD | 1766.67% |
| 2017 FY | - TWD | 119.25% |
| 2017 Q4 | -0.18 TWD | -169.23% |
| 2017 Q3 | 0.26 TWD | -43.48% |
| 2017 Q1 | -0.03 TWD | 98.87% |
| 2016 FY | - TWD | -140.91% |
| 2016 Q4 | -2.44 TWD | -2118.18% |
| 2016 Q3 | -0.11 TWD | -2056.86% |
| 2016 Q2 | -0.01 TWD | 94.34% |
| 2016 Q1 | -0.09 TWD | 86.14% |
| 2015 FY | - TWD | 81.1% |
| 2015 Q1 | -0.30 TWD | 94.02% |
| 2015 Q2 | -0.28 TWD | 6.67% |
| 2015 Q3 | 0.12 TWD | 142.86% |
| 2015 Q4 | -0.65 TWD | -641.67% |
| 2014 FY | - TWD | -1241.18% |
| 2014 Q3 | -0.81 TWD | -107.69% |
| 2014 Q1 | -0.13 TWD | 71.74% |
| 2014 Q4 | -5.02 TWD | -519.75% |
| 2014 Q2 | -0.39 TWD | -200.0% |
| 2013 Q4 | -0.46 TWD | -291.67% |
| 2013 FY | - TWD | -1.92% |
| 2013 Q2 | 0.38 TWD | 8.57% |
| 2013 Q1 | 0.35 TWD | 294.44% |
| 2013 Q3 | 0.24 TWD | -36.84% |
| 2012 Q4 | -0.18 TWD | -122.5% |
| 2012 Q2 | 0.04 TWD | 133.08% |
| 2012 Q1 | -0.12 TWD | -299.0% |
| 2012 Q3 | 0.80 TWD | 1915.11% |
| 2012 FY | - TWD | -27.78% |
| 2011 Q2 | -0.45 TWD | -509.09% |
| 2011 Q1 | 0.11 TWD | -85.33% |
| 2011 FY | - TWD | -74.1% |
| 2011 Q4 | 0.06 TWD | -93.97% |
| 2011 Q3 | 1.00 TWD | 322.22% |
| 2010 Q2 | 0.71 TWD | -15.48% |
| 2010 Q1 | 0.84 TWD | 0.0% |
| 2010 FY | - TWD | 71.6% |
| 2010 Q4 | 0.75 TWD | 59.57% |
| 2010 Q3 | 0.47 TWD | -33.8% |
| 2009 FY | - TWD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Apex Biotechnology Corp. | 1.16 TWD | 67.241% |
| Sinphar Pharmaceutical Co.,Ltd. | 2.24 TWD | 83.036% |
| Panion & Bf Biotech Inc. | 0.90 TWD | 57.778% |
| Chunghwa Chemical Synthesis & Biotech Co., Ltd. | 3.42 TWD | 88.889% |
| Abnova (Taiwan) Corporation | 0.72 TWD | 47.222% |
| Adimmune Corporation | -1.52 TWD | 125.0% |
| Tanvex BioPharma, Inc. | -16.42 TWD | 102.314% |
| Polaris Group | -2.12 TWD | 117.925% |
| Energenesis Biomedical CO.,LTD. | -3.62 TWD | 110.497% |
| UnicoCell Biomed Co., Ltd. | -1.56 TWD | 124.359% |
| PELL Bio-Med Technology Co. Ltd. | -8.62 TWD | 104.408% |